Literature DB >> 18345524

[Challenge prevention. From curative to preventive medicine-strategic and operational challenges].

M P Schönermark1, K Greif.   

Abstract

The potentials of preventive medicine to reduce the costs of illness have been inadequately exploited to date. Even if there is still massive dissent regarding the legal setup of a prevention law, prevention should play a significantly higher role in practice. Clinicians and practitioners could use preventive medicine as another differentiating factor in the increasingly competitive healthcare field. Prevention as a new strategic business segment allows a directed reaction to the demands of the payment system and opens up enormous value-added potential at the same time. Those who seize the chance to integrate prevention into their medical services portfolio and into the structure and processes of their respective hospitals will develop an important competitive advantage for the future.

Mesh:

Year:  2008        PMID: 18345524     DOI: 10.1007/s00106-008-1706-1

Source DB:  PubMed          Journal:  HNO        ISSN: 0017-6192            Impact factor:   1.284


  3 in total

Review 1.  Measuring and monitoring success in compressing morbidity.

Authors:  James F Fries
Journal:  Ann Intern Med       Date:  2003-09-02       Impact factor: 25.391

2.  Expression of epidermal growth factor, tumor necrosis factor-alpha, and interleukin-1alpha in chronic otitis media with or without cholesteatoma.

Authors:  Sertac Yetiser; Bulent Satar; Nizamettin Aydin
Journal:  Otol Neurotol       Date:  2002-09       Impact factor: 2.311

3.  [Pediatric cost-benefit analysis].

Authors:  H Schulze-Gattermann; A Illg; A Lesinski-Schiedat; M Schoenermark; B Bertram; Th Lenarz
Journal:  Laryngorhinootologie       Date:  2003-05       Impact factor: 1.057

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.